Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 40

1.

Crystal structures that suggest late development of genetic code components for differentiating aromatic side chains.

Yang XL, Otero FJ, Skene RJ, McRee DE, Schimmel P, Ribas de Pouplana L.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15376-80. Epub 2003 Dec 11.

2.

tRNA-dependent active site assembly in a class I aminoacyl-tRNA synthetase.

Sherlin LD, Perona JJ.

Structure. 2003 May;11(5):591-603.

3.

ATP binding by glutamyl-tRNA synthetase is switched to the productive mode by tRNA binding.

Sekine S, Nureki O, Dubois DY, Bernier S, Chênevert R, Lapointe J, Vassylyev DG, Yokoyama S.

EMBO J. 2003 Feb 3;22(3):676-88.

4.

Interconversion of ATP binding and conformational free energies by tryptophanyl-tRNA synthetase: structures of ATP bound to open and closed, pre-transition-state conformations.

Retailleau P, Huang X, Yin Y, Hu M, Weinreb V, Vachette P, Vonrhein C, Bricogne G, Roversi P, Ilyin V, Carter CW Jr.

J Mol Biol. 2003 Jan 3;325(1):39-63.

PMID:
12473451
5.

Class I tyrosyl-tRNA synthetase has a class II mode of cognate tRNA recognition.

Yaremchuk A, Kriklivyi I, Tukalo M, Cusack S.

EMBO J. 2002 Jul 15;21(14):3829-40.

6.

Eyeing up tryptophanyl-tRNA synthetase.

Ibba M.

Trends Biochem Sci. 2002 May;27(5):227. No abstract available.

PMID:
12076529
7.
8.
9.

A human aminoacyl-tRNA synthetase as a regulator of angiogenesis.

Wakasugi K, Slike BM, Hood J, Otani A, Ewalt KL, Friedlander M, Cheresh DA, Schimmel P.

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):173-7. Epub 2002 Jan 2.

10.

A fragment of human TrpRS as a potent antagonist of ocular angiogenesis.

Otani A, Slike BM, Dorrell MI, Hood J, Kinder K, Ewalt KL, Cheresh D, Schimmel P, Friedlander M.

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):178-83. Epub 2002 Jan 2.

11.

High-resolution experimental phases for tryptophanyl-tRNA synthetase (TrpRS) complexed with tryptophanyl-5'AMP.

Retailleau P, Yin Y, Hu M, Roach J, Bricogne G, Vonrhein C, Roversi P, Blanc E, Sweet RM, Carter CW Jr.

Acta Crystallogr D Biol Crystallogr. 2001 Nov;57(Pt 11):1595-608. Epub 2001 Oct 25.

PMID:
11679724
12.

Crystal structure of Staphylococcus aureus tyrosyl-tRNA synthetase in complex with a class of potent and specific inhibitors.

Qiu X, Janson CA, Smith WW, Green SM, McDevitt P, Johanson K, Carter P, Hibbs M, Lewis C, Chalker A, Fosberry A, Lalonde J, Berge J, Brown P, Houge-Frydrych CS, Jarvest RL.

Protein Sci. 2001 Oct;10(10):2008-16.

13.

In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection.

Kanamaru T, Nakano Y, Toyoda Y, Miyagawa KI, Tada M, Kaisho T, Nakao M.

Antimicrob Agents Chemother. 2001 Sep;45(9):2455-9.

14.

tRNA aminoacylation by arginyl-tRNA synthetase: induced conformations during substrates binding.

Delagoutte B, Moras D, Cavarelli J.

EMBO J. 2000 Nov 1;19(21):5599-610.

15.

Ancient adaptation of the active site of tryptophanyl-tRNA synthetase for tryptophan binding.

Praetorius-Ibba M, Stange-Thomann N, Kitabatake M, Ali K, Söll I, Carter CW Jr, Ibba M, Söll D.

Biochemistry. 2000 Oct 31;39(43):13136-43.

PMID:
11052665
16.
17.
18.

2.9 A crystal structure of ligand-free tryptophanyl-tRNA synthetase: domain movements fragment the adenine nucleotide binding site.

Ilyin VA, Temple B, Hu M, Li G, Yin Y, Vachette P, Carter CW Jr.

Protein Sci. 2000 Feb;9(2):218-31.

19.

Enzymatic transition-state analysis and transition-state analogs.

Schramm VL.

Methods Enzymol. 1999;308:301-55. No abstract available.

PMID:
10507010
20.

Two distinct cytokines released from a human aminoacyl-tRNA synthetase.

Wakasugi K, Schimmel P.

Science. 1999 Apr 2;284(5411):147-51.

Supplemental Content

Support Center